Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
Cerus announced inclusion of pathogen reduction technology in ISBT recommendations for preparation of COVID-19 convalescent plasma
On Apr. 2, 2020, Cerus announced that the International Society of Blood Transfusion (ISBT) Working Party on Global…
University Hospital Basel, Switzerland transfused first two COVID-19 patients with INTERCEPT treated Coronavirus convalescent plasma
On Apr. 2, 2020, Cerus announced that the University Hospital Basel transfused the first two COVID-19 patients with…
Cerus formed group to research optimal production of COVID-19 convalescent plasma
On Mar. 26, 2020, Cerus announced it had formed a collaborative research group with the aim of optimizing…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Life Science News | Vaccine
serum therapy used as possible COVID-19 treatment
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
Monkeys developed protective antibodies to SARS-CoV-2
On Mar. 17, 2020, a small study of macaques found they don’t develop a coronavirus infection the second…
BioAegis announced publication: ‘Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza’
On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…
Nanomix received CE Mark for diagnostic panel that aids in rapid identification of life-threatening infections
On Dec. 4. 2019, Nanomix announced that the company had received CE Mark for its S1 Assay for…
CDC published updated dosing instructions for hepatitis A prophylaxis with immune globulin
On Sept. 15, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated GamaSTAN S/D prescribing…
Grifols opened state-of-the-art facility in Clayton to advance treatment of rare and life-threatening diseases
On Jun. 17, 2014, Grifols opened state-of-the-art North Fractionation Facility (NFF) in Clayton, NC, where production capacity of…
Researchers described successful construction of the first self-replicating, synthetic bacterial cell
On May 20, 2010, researchers at the J. Craig Venter Institute in Maryland published results describing the successful…
The FDA approved the first nucleic acid test system to screen whole blood donors for infections with HIV and HCV
On Feb. 28, 2002, the FDA announced it had licensed the first nucleic acid test (NAT) system intended…
FDA approved Hybritech antibody test for prostate cancer – a first
In February 1986, the U.S. Food and Drug Administration (FDA) approved Hybritech’s Tandem-R PSA assay (P850048) with calibration…
Discovery that treatment with human recombinant interferon gamma blocks the growth of T. gondii published
On Feb. 8, 1984, Elmer R. Pfefferkorn published his discovery that treatment of human fibroblasts with human recombinant…
U.S. blood banking groups issued their first warning about AIDS
On Jun. 22, 1983, the American Association of Blood Banks, the Council of Community Blood Centers, and the…
Biotechnology | CDC | Diagnostics | HIV | Life Science News
The CDC received funding for HIV risk reduction services for people with hemophilia
On Jan. 4, 1983, epidemiologic evidence that the AIDS agent was blood-borne led to official meetings and public…
The first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were licensed Both had independently developed plasma-based hepatitis B viral vaccines
In 1982, the first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were…
First human viral vaccine to prevent cancer (hepatitis B vaccine for liver cancer) was introduced
In 1981, the U.S. Food and Drug Administration (FDA) approved a plasma-derived hepatitis B vaccine for human use….
Insulin resistance receptors was discovered
On Apr. 1, 1976, physician and scientist C. Ronald Kahn from Harvard University announced he had discovered alterations…
Cook County Hospital became the first hospital to use an all frozen blood banking system
In 1972, Cook County Hospital became the first hospital to use an all frozen blood banking system. This…
The FDA began to regulate all 7000 US blood and plasma centers
In 1972, the FDA’s new Bureau of Biologics began to regulate all 7000 U.S. blood and plasma centers….
Pioneering work in inductively coupled plasma spectroscopy at Iowa State University led to an analysis tool that’s standard laboratories worldwide
In 1966, pioneering work in inductively coupled plasma spectroscopy at Iowa State University led to an analysis tool…
Plasmapheresis was introduced as a means of collecting plasma for fractionation
In 1964, plasmapheresis was introduced as a means of collecting plasma for fractionation.
Plastic blood bag was invented
In 1953, William P. Murphy, Jr., an American doctor working with colleague Carl Walter, developed the blood bag…
Velmer A Fassel, a chemist who developed the inductively coupled plasma, received a PhD from Iowa State University
In 1947, Velmer A. Fassel, an American chemist who developed the inductively coupled plasma, received in Ph.D. from…
Dried plasma used to treatiwounded solders in World War II
In 1944, the use of dried plasma became vital to treating wounded solders in World War II.
Velmer A Fassel, a chemist who developed the inductively coupled plasma, received a BA degree at Southeast Missouri State College
In 1941, Velmer A. Fassel, an American chemist who developed the inductively coupled plasma, received a B.A. degree…
Edwin Cohn developed cold ethanol fractionation
In 1940, Edwin Cohn, a professor of biological chemistry at Harvard Medical School, developed cold ethanol fractionation, the…
Charles R Drew began blood processing program for English war victims: Plasma for Britain
In 1940, Charles R. Drew, MD, an African American surgeon and Howard University researcher, began an early blood…